A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)
Clinical trial NCT03314922 · COMPLETED
Trial details
- NCT number
- NCT03314922
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2020-05-05
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.